Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Beauty Health ( (SKIN) ).
On July 31, 2025, The Beauty Health Company filed a Certificate of Correction to amend an error in its corporate governance documents, allowing directors to be removed with or without cause by a majority vote. Additionally, the Board appointed Stephen Fanning as Chairman of the Nominating and Corporate Governance Committee, reflecting a strategic move in its leadership structure.
The most recent analyst rating on (SKIN) stock is a Hold with a $1.20 price target. To see the full list of analyst forecasts on Beauty Health stock, see the SKIN Stock Forecast page.
Spark’s Take on SKIN Stock
According to Spark, TipRanks’ AI Analyst, SKIN is a Neutral.
Beauty Health’s overall stock score reflects significant financial challenges, with high leverage and negative profitability weighing heavily. Despite positive developments such as improved cash flow and strategic debt refinancing, bearish technical indicators and valuation concerns remain. The earnings call provided some optimism with strong performance in consumables and improved gross margins, but these are overshadowed by macroeconomic pressures and declining sales in key regions.
To see Spark’s full report on SKIN stock, click here.
More about Beauty Health
The Beauty Health Company operates in the beauty and health industry, focusing on products and services that enhance personal care and wellness.
Average Trading Volume: 981,487
Technical Sentiment Signal: Sell
Current Market Cap: $194.1M
Find detailed analytics on SKIN stock on TipRanks’ Stock Analysis page.